Clinical trial
Dendritic Cells as Autologous Vaccine in Patients With Chronic Myeloid Leukemia
NCT02543749 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dendritic Cells as Autologous Vaccine in Patients With Chronic Myeloid Leukemia
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- July 31, 2014
- Completion date
- July 31, 2022
- Enrollment
- 1 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
myeloid leukemia, chronic